Media center
Press release
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Built by biologists, for biologists. Free to use for academic researchers.
May 6, 2025
Press release
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Built by biologists, for biologists. Free to use for academic researchers.
May 6, 2025
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
May 6, 2025
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
May 6, 2025
Press release
Owkin Appoints Graeme Bell as Chief Financial Officer
May 5, 2025
Owkin Appoints Graeme Bell as Chief Financial Officer
May 5, 2025
Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
In the media
EY features Owkin's CEO Thomas Clozel in the "Grow Fast, Now What?" podcast (FR)
February 18, 2025
EY features Owkin's CEO Thomas Clozel in the "Grow Fast, Now What?" podcast (FR)
February 18, 2025
EY
In the media
Wall Street Journal features CEO Thomas Clozel
February 10, 2025
Wall Street Journal features CEO Thomas Clozel
February 10, 2025
WSJ
In the media
Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit
February 9, 2025
Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit
February 9, 2025
Les Echos
In the media
Owkin’s CEO, Thomas Clozel named in Le Figaro’s top 7 french leaders in AI
February 6, 2025
Owkin’s CEO, Thomas Clozel named in Le Figaro’s top 7 french leaders in AI
February 6, 2025
Le Figaro
In the media
France 24 covers Owkin’s Glioblastoma AI Hackathon
February 4, 2025
France 24 covers Owkin’s Glioblastoma AI Hackathon
February 4, 2025
France 24
In the media
STAT interviews Owkin SVP Andrew Pierce about OKN4395
January 30, 2025
STAT interviews Owkin SVP Andrew Pierce about OKN4395
January 30, 2025
STAT
Press release
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Owkin announces first patient dosed in Phase 1 Clinical Trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for patients with solid tumors
January 30, 2025
Press release
Owkin announces Owkin K1.0 Turbigo, a cutting-edge operating system to create the first AGI for biology, at JP Morgan Healthcare Conference
January 13, 2025
Owkin announces Owkin K1.0 Turbigo, a cutting-edge operating system to create the first AGI for biology, at JP Morgan Healthcare Conference
January 13, 2025